What is Algorae Pharmaceuticals Price-to-Operating-Cash-Flow?
As of today (2024-06-08), Algorae Pharmaceuticals's share price is A$0.0115.
Algorae Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.00. Hence, Algorae Pharmaceuticals's Price-to-Operating-Cash-Flow Ratio for today is .
The historical rank and industry rank for Algorae Pharmaceuticals's Price-to-Operating-Cash-Flow or its related term are showing as below:
During the past 13 years, Algorae Pharmaceuticals's highest Price-to-Operating-Cash-Flow Ratio was 25.95. The lowest was 9.44. And the median was 18.05.
Algorae Pharmaceuticals's Cash Flow from Operations per share for the
six
months ended in Dec. 2023 was A$-0.00.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.00.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 41.50% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 27.20% per year.
During the past 13 years, Algorae Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 41.50% per year. The lowest was -4.60% per year. And the median was 20.30% per year.
Algorae Pharmaceuticals Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Algorae Pharmaceuticals's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Algorae Pharmaceuticals Price-to-Operating-Cash-Flow Chart
|
Algorae Pharmaceuticals Annual Data
|
|
Trend |
Jun14 |
Jun15 |
Jun16 |
Jun17 |
Jun18 |
Jun19 |
Jun20 |
Jun21 |
Jun22 |
Jun23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
- |
- |
- |
- |
- |
|
Algorae Pharmaceuticals Semi-Annual Data
|
|
Jun14 |
Dec14 |
Jun15 |
Dec15 |
Jun16 |
Dec16 |
Jun17 |
Dec17 |
Jun18 |
Dec18 |
Jun19 |
Dec19 |
Jun20 |
Dec20 |
Jun21 |
Dec21 |
Jun22 |
Dec22 |
Jun23 |
Dec23 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
- |
- |
- |
- |
Competitive Comparison of Algorae Pharmaceuticals's Price-to-Operating-Cash-Flow
For the Biotechnology subindustry, Algorae Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Algorae Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Algorae Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Algorae Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.
Algorae Pharmaceuticals Price-to-Operating-Cash-Flow Calculation
Algorae Pharmaceuticals's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 0.0115 | / | -0.002 |
| = | |
Algorae Pharmaceuticals's Share Price of today is A$0.0115.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Algorae Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Algorae Pharmaceuticals (ASX:1AI) Business Description
Traded in Other Exchanges
Address
201 Sussex Street, Level 16, Tower 2, Darling Park, Sydney, NSW, AUS, 2000
Algorae Pharmaceuticals Ltd is a clinical-stage pharmaceutical company developing transformative solutions for undermet medical needs in the community. The firm develops AlgoraeOS, a closed-loop platform, leveraging computational tools to generate novel insights in silico that are being developed to initiate or accelerate therapeutic programs. Its lead products comprise AI-116, a novel combination drug candidate of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. It is conceptualised to be a potential treatment for dementia, including Alzheimer's disease; NTCELL is an alginate-coated capsule containing clusters of neonatal porcine choroid plexus cells. It also offers LP-003 Anti-obesity Drug and LC-002 migraine treatment.
Algorae Pharmaceuticals (ASX:1AI) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASX:1AI has been successfully added to your